Evidence map›Paper›PMID 32015528›Full record

ReviewNature reviews. Cardiology2020

Cardiomyocyte maturation: advances in knowledge and implications for regenerative medicine.

Elaheh Karbassi, Aidan Fenix, Silvia Marchiano, Naoto Muraoka, Kenta Nakamura, Xiulan Yang, Charles E Murry

Open access · greenAbstract readReview
In one paragraph

Review in Nature reviews. Cardiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 475 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
475citing papers in PubMed, 1 pooled it
87.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

475 citing papers in PubMed, 1 synthesis or guideline pooled it, 731 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. A highly penetrantbioRxiv : the preprint server for biology · 2026
    Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Non-transferrin-bound iron uptake by cardiomyocytes.Journal of molecular medicine (Berlin, Germany) · 2026
    Review

415 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Elaheh KarbassiInstitute for Stem Cell and Regenerative Medicine, University of Washington, Seattle, WA, USA.
Aidan FenixInstitute for Stem Cell and Regenerative Medicine, University of Washington, Seattle, WA, USA.
Silvia MarchianoInstitute for Stem Cell and Regenerative Medicine, University of Washington, Seattle, WA, USA.
Naoto MuraokaInstitute for Stem Cell and Regenerative Medicine, University of Washington, Seattle, WA, USA.
Kenta NakamuraInstitute for Stem Cell and Regenerative Medicine, University of Washington, Seattle, WA, USA.
Xiulan YangInstitute for Stem Cell and Regenerative Medicine, University of Washington, Seattle, WA, USA.
Charles E MurryInstitute for Stem Cell and Regenerative Medicine, University of Washington, Seattle, WA, USA. murry@uw.edu.ORCID http://orcid.org/0000-0003-3862-6773
University of Washington · USCalifornia Institute for Regenerative Medicine · US

Funding

University of Washington Center for Nuclear Organization and FunctionU54DK107979 · NIDDK · UNIVERSITY OF WASHINGTON · PI NOBLE, WILLIAM STAFFORD, SHENDURE, JAY ASHOK · 2015 to 2019
$11.8M
Engineered Stem Cells for Cardiac RepairR01HL128368 · NHLBI · UNIVERSITY OF WASHINGTON · PI REGNIER, MICHAEL · 2018 to 2025
$6.1M
Primate Heart RegenerationR01HL128362 · NHLBI · UNIVERSITY OF WASHINGTON · PI MURRY, CHARLES E · 2016 to 2019
$3.5M
Mechanisms of Cell-Based Heart RegenerationR01HL146868 · NHLBI · UNIVERSITY OF WASHINGTON · PI MURRY, CHARLES E, SNIADECKI, NATHAN JOHN · 2019 to 2022
$3.5M
Perfusable 3D human cardiac constructs for heart regenerationR01HL141570 · NHLBI · UNIVERSITY OF WASHINGTON · PI MURRY, CHARLES E, ZHENG, YING · 2018 to 2021
$3.3M
NHLBI NIH HHS R01 HL128362NHLBI NIH HHS R01 HL128368NHLBI NIH HHS R01 HL141570NHLBI NIH HHS R01 HL146868NIDDK NIH HHS U54 DK107979
6 · The paper itself

Abstract

Our knowledge of pluripotent stem cell (PSC) biology has advanced to the point where we now can generate most cells of the human body in the laboratory. PSC-derived cardiomyocytes can be generated routinely with high yield and purity for disease research and drug development, and these cells are now gradually entering the clinical research phase for the testing of heart regeneration therapies. However, a major hurdle for their applications is the immature state of these cardiomyocytes. In this Review, we describe the structural and functional properties of cardiomyocytes and present the current approaches to mature PSC-derived cardiomyocytes. To date, the greatest success in maturation of PSC-derived cardiomyocytes has been with transplantation into the heart in animal models and the engineering of 3D heart tissues with electromechanical conditioning. In conventional 2D cell culture, biophysical stimuli such as mechanical loading, electrical stimulation and nanotopology cues all induce substantial maturation, particularly of the contractile cytoskeleton. Metabolism has emerged as a potent means to control maturation with unexpected effects on electrical and mechanical function. Different interventions induce distinct facets of maturation, suggesting that activating multiple signalling networks might lead to increased maturation. Despite considerable progress, we are still far from being able to generate PSC-derived cardiomyocytes with adult-like phenotypes in vitro. Future progress will come from identifying the developmental drivers of maturation and leveraging them to create more mature cardiomyocytes for research and regenerative medicine.

Indexed as

Regenerative MedicineAnimalsCell Culture TechniquesCell DifferentiationHumansMetabolomeMyocytes, CardiacPluripotent Stem CellsProteomeStem Cell TransplantationTissue EngineeringTranscriptomeProteome

Identifiers

PMID32015528
PMCPMC7239749
OpenAlexW3004299218

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.